SkinBioTherapeutics (LSE:SBTX) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:SBTX SkinBioTherapeutics PLC LSE:SBTX
37 GF Score
Price £0.11
GF Value £0.66
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is SkinBioTherapeutics Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LSE:SBTX
37GF Score
SkinBioTherapeutics PLC LSE:SBTX
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is SkinBioTherapeutics (LSE:SBTX) Overvalued in 2026?

Based on GuruFocus' analysis, SkinBioTherapeutics stock appears to be undervalued. The current stock price of £0.11 is trading 83% below its estimated GF Value™ of £0.66. GuruFocus considers SkinBioTherapeutics to be Possible Value Trap.

Key valuation signals for LSE:SBTX:

  • Short Ratio:
  • GF Value™: £0.66 vs. price of £0.11 (83% below fair value)
  • GF Score™: 37/100 with 3 warning signs

No single metric tells the full story. See the LSE:SBTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SkinBioTherapeutics Business Description

Address Bath Lane, The Core, Newcastle Helix, Newcastle upon Tyne, GBR, NE4 5TF
SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage, and restore skin utilizing proteins found in the human microbiota. It is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema.
37GF Score

Get the complete analysis for LSE:SBTX

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.11
Price
£0.66
GF Value